Cover Image

Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Flory T. Muanda, Matthew A. Weir, Fatemeh Ahmadi, Eric McArthur, Jessica M. Sontrop, Sheikh S. Abdullah, Brad L. Urquhart, Hasti Sadeghi, Richard B. Kim, Amit X. Garg
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
by: Nicholas C. Tonial, et al.
Published: (2025)

Co‐prescription of low‐dose methotrexate and trimethoprim‐sulfamethoxazole and the 30‐day risk of death among older adults: A cohort study
by: Hasti Sadeghi, et al.
Published: (2024)

Prevalence of potentially inappropriately prescribed medications among older adults receiving peritoneal dialysis
by: Armando Silva Almodovar, et al.
Published: (2025)

Transdermal rivastigmine as a therapeutic option in severe diphenhydramine‐induced anticholinergic toxicity: A case report and literature review
by: Brian W. Gilbert, et al.
Published: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
by: Trisha Matsuura, et al.
Published: (2025)

Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors
by: Kellye Eagan, et al.
Published: (2025)

Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data
by: Ashna Talwar, et al.
Published: (2024)

Comment on “Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time‐series analysis of Medicare data”
by: Shih‐Jie Wang, et al.
Published: (2025)

Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018
by: Mahek Garg, et al.
Published: (2024)

Assessment of the association between mixed‐oil lipid injectable emulsion use and 30‐day mortality or infection persistence from fungal catheter‐related bloodstream infections in pediatric patients following receipt of parenteral nutrition: A retrospective cohort study
by: Gustavo R. Alvira‐Arill, et al.
Published: (2025)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
by: Alexandre Duong, et al.
Published: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
by: Maryam Aghakouchakzadeh, et al.
Published: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
by: Seonga Song, et al.
Published: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
by: Mohammed Al Musawa, et al.
Published: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
by: Atif Siddiqui
Published: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
by: Jiwon Kim, et al.
Published: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
by: Hua‐Ping Fan, et al.
Published: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
by: Keith A. Rodvold
Published: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
by: Nicolette Centanni, et al.
Published: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
by: Yi‐Fan Chien, et al.
Published: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
by: Amanda Massmann, et al.
Published: (2025)

In Search of Big Beautiful Biomarkers
by: C. Lindsay DeVane
Published: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
by: Carlos Augusto Espinoza Cobeñas
Published: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
by: Lisa T. Hong, et al.
Published: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
by: Nihal El Rouby, et al.
Published: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
by: Amira R. Rashdan, et al.
Published: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
by: Kathleen A. Stringer, et al.
Published: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
by: Shibing Tao, et al.
Published: (2024)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
by: Ashlan J. Kunz Coyne, et al.
Published: (2026)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
by: Jennifer N. Clements, et al.
Published: (2026)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
by: Susan E. Smith, et al.
Published: (2026)

Issue Information
Published: (2026)

External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring
by: Mathieu Blouin, et al.
Published: (2024)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
by: Amy Broadwater, et al.
Published: (2026)

The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review
by: Hansa Mreyoud, et al.
Published: (2024)

Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection
by: Javeria Khalid, et al.
Published: (2026)

Comment on “The power and pitfalls of underpowered studies”
by: Chia Siang Kow, et al.
Published: (2024)

Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy
by: Ashwin Karanam, et al.
Published: (2025)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Published: (2025)

Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation
by: Spenser E. January, et al.
Published: (2025)